IndPages

Indian businessConsumer and pharma

Serum Institute of India

The Serum Institute of India is a Pune based vaccine maker founded in 1966 by Cyrus Poonawalla, and described by the company as the largest vaccine producer by doses.

Maharashtra

Cyrus Poonawalla came from a family that bred horses and began using horse serum to make anti snake venom and tetanus products at the Poona Stud farm. He started the Serum Institute in 1966 in Pune to make serum based biological products, and gradually expanded into vaccines.

The company began with vaccines against tetanus, diphtheria and pertussis, and later made measles, hepatitis B and other vaccines at low prices for international buyers, including United Nations agencies. A large share of its output is exported to many countries.

During the COVID-19 pandemic, it manufactured the Oxford AstraZeneca vaccine under the name Covishield and, later, the Novavax vaccine under licence. It is privately held, and Adar Poonawalla serves as its chief executive. The headquarters and main plants are in Pune, Maharashtra. The company also invests in research on new vaccines, including those for malaria and other diseases that affect developing countries.

Sources

  1. Serum Institute of India

Written for IndPages in original words from the sources above. Last checked 17 November 2026.

See something to add or correct? Suggest a correction to this page.